. Author manuscript; available in PMC: 2014 Sep 19.

Published in final edited form as: Cochrane Database Syst Rev. 2010 Jan 20;(1):CD006625. doi: 10.1002/14651858.CD006625.pub2

Analysis 4.16. Comparison 4 QUETIAPINE versus ZIPRASIDONE, Outcome 16 Adverse effects: 7c. Metabolic - weight gain of 7% or more of total body weight.

Review: Quetiapine versus other atypical antipsychotics for schizophrenia

Comparison: 4 QUETIAPINE versus ZIPRASIDONE

Outcome: 1 6 Adverse effects: 7c. M etabolic - weight gain of 7% or m ore of total body weight